6
J. Zhang et al. / Polymer 116 (2017) 5e15
redox properties, and polymerization of selected DA derivatives
2 4
Na HPO (273 mg, 1.92 mmol) was added to the reaction mixture
have been investigated [14e16]. For example, DA derivatives with
electron-withdrawing groups such as -NO [15] and -Cl [16] groups
2
and refluxed for 1 h. The reaction mixture was subsequently filtered
and the filtered solid was rinsed with water. The filtrate collected
was acidified with 6 N HCl until acidic. The resulting mixture was
evaporated at 60 C under reduced pressure (30 mmHg) until a
thick slurry remained. The slurry was dissolved in ethyl acetate
have lower oxidation potentials and polymerization rates as
compared to DA [16]. This suggests that the introduction of an
electron-donating group on the catechol ring of DA should increase
its susceptibility to oxidation, and the rate of polymerization and
deposition should be accelerated. It may also be possible to use the
DA derivative with an electron-donating group for incorporating
silver nanoparticles (AgNPs) for applications as antibacterial coat-
ings. Polymerization of 5-hydroxyl substituted dopamine for sur-
face modification has been reported [17], but to the best of our
knowledge, the possibility that an electron-donating group on the
catechol ring can accelerate the polymerization of DA derivatives
has not been investigated. To verify these hypotheses, the poly-
merization of DA and 5-methoxy DA (OMeDA), as well as their
applications in surface modification and AgNP deposition were
investigated and compared.
ꢀ
4
(500 mL), then dried with MgSO , filtered and evaporated. The
crude residue was purified by flash chromatography (5% MeOH/
DCM) to give compound 2 (6 g, yield of 90%) as a light brown solid
ꢀ
1
[18] with mp 131e133 C. H NMR (400 MHz, CDCl
7.14 (d, J ¼ 1.7 Hz, 1H), 7.08 (d, J ¼ 1.7 Hz, 1H), 3.97 (s, 3H). C NMR
(101 MHz, DMSO) 191.3,148.5,145.9,141.1,127.4,110.9,105.0, 56.0.
ESI-MS: m/z 167.3 for C
3
): d 9.79 (s, 1H),
13
d
-
8 9 4
H O ([M - H] , calculated m/z 167.0).
2.2.3. Synthesis of (E)-(((3-methoxy-5-(2-nitrovinyl)-1,2-
phenylene)bis(oxy)) bis(methylene))dibenzene (compound 3)
Benzyl bromide (7.73 mL, 65.0 mmol) and potassium iodide
(1.29 g, 7.78 mmol) were subsequently added to a suspension of
2 3
compound 2 (4.37 g, 26.0 mmol) and K CO (17.96 g,130.0 mmol) in
2
. Experimental section
N,N-dimethylformamide (DMF) under nitrogen. The reaction
mixture was heated at 80 C for 4 h, and then cooled to RT followed
ꢀ
2.1. Materials
2 3
by the removal of K CO by filtration. The mixture was subse-
quently extracted with 500 mL of ethyl acetate and washed with
1 N HCl and brine. The crude product was dried over anhydrous
Silicon (Si) wafers were obtained from Mitsubishi Silicon
America, USA. Tris was obtained from Vivantis Technologies,
Singapore. Deuterium oxide and Tris-d11 were purchased from
Cambridge Isotope Laboratories, USA. Staphylococcus aureus
2 4
Na SO , and the solvent was removed under reduced pressure. The
product (9.15 g, 26.3 mmol) and ammonium acetate (6.07 g,
78.7 mmol) were dissolved in acetic acid, and nitromethane
(7.09 mL, 131.3 mmol) was added to the reaction mixture. The re-
action mixture was refluxed for 5 h, cooled to RT and then poured
into water. The aqueous phase was extracted three times with
(S. aureus) 25923 was purchased from American Type Culture
Collection (Manassas, VA). All other chemicals, if not specified,
were purchased from Sigma-Aldrich.
200 mL ethyl acetate. The combined organic phases were washed
2
2
.2. Synthesis of OMeDA
with brine (200 mL), dried over anhydrous Na SO , and concen-
trated under reduced pressure. The residue was subjected to flash
2
4
.2.1. General experimental procedures
Thin layer chromatography was performed on precoated silica
chromatography (50% dichloromethane/petroleum ether) to give
ꢀ
1
compound 3 (8 g, yield of 79%) with mp 126e128 C. H NMR
(400 MHz, CDCl
7.89 (d, J ¼ 13.5 Hz, 1H), 7.48 (d, J ¼ 13.5 Hz, 1H),
7.45e7.27 (m, 10H), 6.79 (d, J ¼ 2.0 Hz, 1H), 6.75 (d, J ¼ 2.0 Hz, 1H),
gel plates (Merck, Singapore) and visualized with UV light irradi-
ation. Compounds 2, 3 and 4 (in Scheme 1a) were purified by flash
chromatography on a column using Merck silica gel 60 (230e400
mesh) or reversed-phase preparative chromatography using a
RediSep Rf Gold C18Aq column attached to a Sepacore flash X10
system. Low-resolution electrospray ionization mass spectra
3
) d
13
3
5.12 (s, 4H), 3.88 (s, 3H). C NMR (101 MHz, CDCl ) d 154.4, 153.2,
141.5, 139.4, 137.4, 136.5 (2C), 128.8 (2C), 128.6 (2C), 128.4 (2C),
®
®
128.3, 128.2, 127.5 (2C), 125.5, 108.9, 106.8, 75.4, 71.6, 56.5. HRMS:
þ
m/z 392.1500 for C23
H22NO
5
([M þ H] , calculated m/z 392.1492).
(
2
LRESIMS) were recorded on an Applied Biosystems MDS SCIEX API
000 mass spectrometer. High resolution mass spectra (HRMS)
2.3. Synthesis of OMeDA
were recorded on an Agilent mass spectrometer (electrospray
ionization (ESI)-time of flight). Melting points (mp) were deter-
mined using a SRS OptiMelt MPA100 mp apparatus. Nuclear mag-
netic resonance (NMR) spectra were recorded on a Bruker
Palladium on carbon (10%, 1 g) and 6 N HCl (1.0 mL) were added
to a suspension of compound 3 (1 g, 2.55 mmol) in a solution of
ethanol and tetrahydrofuran (1:1) under nitrogen in a glass vessel.
The vessel was flushed with hydrogen gas and pressurized to
345 kPa. The reaction mixture was stirred at RT for 15 min following
which the hydrogen gas was removed by bubbling nitrogen gas
through the mixture. The reaction mixture was then filtered
through celite and the filtrate was concentrated under reduced
pressure. The residue was purified by reversed-phase chromatog-
1
spectrometer (Avance III 400 MHz) at 400 MHz for H and 100 MHz
1
3
for C using chloroform-d, methanol-d
DMSO)-d as solvent. The chemical shifts are given in ppm, using
the proton solvent residue signal (CDCl 7.26, CD OD: 3.31,
SO: 2.50) as a reference in the H NMR spectra. The deute-
rium coupled signal of the solvent (CDCl 77.16, CD OD: 49.00,
CD SO: 39.52) was used as a reference in C NMR spectra. The
4
or dimethyl sulfoxide
(
6
3
:
d
3
d
1
(
3 2
CD )
3
:
d
3
d
13
(
3
)
2
raphy (95% H
250 mg, 45%) as a pale brown solid with mp 190e192 C. H NMR
(400 MHz, CD OD) spectrum:
6.41 (d, J ¼ 1.9 Hz, 1H), 6.38 (d,
2
O/methanol) to produce OMeDA (compound 4,
ꢀ
1
following abbreviations were used to describe the signals:
s ¼ singlet, d ¼ doublet, t ¼ triplet, m ¼ multiplet and q ¼ quartet.
The synthetic route to OMeDA is shown in Scheme 1a, and
described below:
3
d
1
3
J ¼ 1.9 Hz, 1H), 3.84 (s, 3H), 3.12 (t, 2H), 2.81 (t, 2H). C NMR
(101 MHz, CD
3
OD) spectrum:
d
150.0, 146.7, 134.1, 128.5, 110.3,
þ
1
05.2, 56.7, 42.3, 34.3. HRMS: m/z 184.1 for C
9
H
14NO
3
([M þ H] ,
2.2.2. Synthesis of 3,4-dihydroxy-5-methoxybenzaldehyde
calculated m/z 184.1).
(compound 2)
To a suspension of 5-bromovanillin (1, 9.2 g, 38.4 mmol) and
2.4. Polymerization of OMeDA or DA in solution
NaOH (15.4 g, 384.8 mmol) in degassed water (400 mL), was added
Cu powder (123 mg, 1.92 mmol) at room temperature (RT). The
reaction mixture was refluxed for 60 h and then cooled down to RT.
DA or OMeDA (0.3 mM) was dissolved in Tris buffer (10 mM, pH
8.5), and the reaction mixture was incubated at 37 C with shaking
ꢀ